Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.
Motoi Suzuki, B. G. Dhoubhadel, T. Ishifuji, M. Yasunami +7 more

